Sun Pharma-Organon $11.75 billion deal - 5 ‘must know’ details - Stock surges 7%
Published on: April 27, 2026, 11:11 a.m. | Source: The Financial Express
From nearly doubling EBITDA to becoming a top player in biosimilars and women’s health, here are five key takeaways investors should track.
